Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112679336A reveals a green heterogeneous Pd@POL catalytic route for phenylpropionic acids, offering reduced heavy metal residues and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN110256211B reveals a photoredox method for 1,1-diarylalkane derivatives. Offers mild conditions and cost reduction in fine chemical manufacturing for global supply chains.
Patent CN101402582A reveals a novel one-step four-component reaction for high-purity pharmaceutical intermediates. This method significantly reduces cost and improves supply chain reliability.
Patent CN114315906B discloses novel chiral phosphite ligands enabling high-yield asymmetric hydrosilylation and hydroformylation for reliable pharmaceutical intermediate supplier networks.
Patent CN108752290B details a high-yield TTP/HFIP catalytic route for benproperine phosphate, offering significant cost reduction and purity improvements for API manufacturers.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Novel metal-free synthesis of functionalized allenones using N-heterocyclic carbene catalysts. Offers high atom economy and scalability for pharmaceutical intermediates.
Patent CN102558004A reveals a mild, high-yield synthesis route for S-(4-tolyl)benzenesulfonate, offering significant cost reduction and supply chain stability for fine chemical manufacturing.
Patent CN118344244A enables visible light catalyzed deuteration using D2O. Offers cost reduction and scalable supply for high-purity pharmaceutical intermediates.
Patent CN100564365C details a streamlined 2-step synthesis for Anastrozole, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Novel ruthenium catalyst enables low-loading synthesis of quinoline derivatives reducing costs and improving supply chain reliability for pharmaceutical intermediates.
Patent CN106242935A reveals a green water-oil two-phase synthesis for triaryl chiral compounds. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105017334A reveals single Λ-configuration cobalt catalysts. Enhances asymmetric synthesis efficiency and supply chain stability for pharmaceutical intermediates.
Patent CN108947880B reveals a metal-free visible light method for thiocarbamates. Eliminate toxic phosgene, reduce costs, and ensure supply continuity with our advanced green chemistry solutions.
Patent CN102010376B details an aqueous phase synthesis for quinoxalines using biodegradable ionic liquids, offering high yields and eco-friendly processing for pharmaceutical intermediates.
Patent CN103450073A details a novel rigid chiral catalyst synthesis offering superior stereoselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Patent CN103333049A reveals a recyclable phosphotungstic acid ionic liquid catalyst for styrene oxide alcoholysis, offering high purity and reduced waste for pharmaceutical intermediate manufacturing.
Patent CN116354930A reveals a novel Pd/Cu catalyzed route for synthesizing chiral tetrahydroquinolines from amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel visible light method reduces metal waste. Enhances supply chain stability for high-purity pharmaceutical intermediates. Cost-effective scalable production.
Novel one-step synthesis method for high-purity calix[8]arene phosphates. Enhances rare earth separation efficiency with scalable industrial production capabilities.